ROOTOPTIN-25 Azathioprine 25 mg Tablets Division: DIABGLYM Composition Each tablet contains: Azathioprine IP — 25 mg Excipients — q.s. Colour: Approved colour used Dosage form: Oral tablet Product Description ROOTOPTIN-25 contains Azathioprine 25 mg, an immunosuppressive and immunomodulatory medication formulated for the management of autoimmune disorders, inflammatory diseases, and prevention of organ transplant rejection. Azathioprine is a purine analog that suppresses abnormal immune responses by inhibiting lymphocyte proliferation and reducing immune-mediated tissue damage. Azathioprine is widely prescribed in rheumatology, nephrology, gastroenterology, dermatology, and transplant medicine for long-term immune modulation. It is particularly beneficial in conditions where excessive immune activation contributes to chronic inflammation and progressive organ damage. ROOTOPTIN-25 helps maintain disease remission, reduce autoimmune activity, minimize corticosteroid requirements, and support long-term management of chronic immune-mediated disorders under specialist supervision. Technical Knowledge of Azathioprine Azathioprine is a prodrug that is converted into 6-mercaptopurine and active thioguanine nucleotides, which inhibit purine synthesis and DNA replication. This selectively suppresses rapidly proliferating immune cells, particularly T and B lymphocytes, resulting in reduced antibody production, decreased cell-mediated immune responses, and attenuation of chronic inflammatory processes. Because Azathioprine affects immune cell proliferation, therapeutic response may take several weeks to develop, making it suitable for long-term maintenance therapy rather than immediate symptom control. Mechanism of Action Azathioprine inhibits purine nucleotide synthesis, suppresses T-lymphocyte and B-lymphocyte proliferation, reduces antibody formation, decreases cell-mediated immune responses, and helps control chronic autoimmune and inflammatory activity. Key Benefits Effective immunosuppressive therapy Helps maintain remission in autoimmune diseases Reduces immune-mediated inflammation Supports long-term disease control May reduce corticosteroid requirements Helps prevent organ transplant rejection Suitable for chronic immune modulation under medical supervision Clinical Applications ROOTOPTIN-25 is commonly prescribed for rheumatoid arthritis, systemic lupus erythematosus, autoimmune hepatitis, inflammatory bowel disease including ulcerative colitis and Crohn’s disease, nephrotic syndrome, vasculitis, dermatological autoimmune disorders, and prevention of organ transplant rejection. Facts About Azathioprine Azathioprine has been extensively used worldwide for autoimmune and transplant indications. It is considered an important steroid-sparing immunosuppressive agent and is widely recommended in multiple clinical guidelines for long-term management of autoimmune disorders. Regular monitoring of complete blood counts and liver function tests is recommended during therapy to ensure safety and optimize treatment outcomes. Key Facts Purine analog immunosuppressive agent Azathioprine 25 mg for long-term immune modulation Effective in autoimmune and inflammatory disorders Supports maintenance therapy and disease remission Widely used in rheumatology, nephrology, gastroenterology, and transplant medicine Quality-assured pharmaceutical formulation PCD Pharma Franchise Opportunity ROOTOPTIN-25 is an excellent product for PCD Pharma Franchise, Specialty Pharma Franchise, and Immunology Franchise across India. The increasing prevalence of autoimmune disorders, inflammatory diseases, and organ transplant care creates strong prescription demand and long-term market potential for this formulation. Why Choose ROOTOPTIN-25 for PCD Pharma Franchise? High prescription potential Strong physician and specialist acceptance Attractive monopoly franchise opportunity Competitive pricing Promotional support available Visual aids and marketing inputs Consistent product quality Excellent repeat business potential Third Party Manufacturing Chemsroot Pharmaceutical offers Third Party Manufacturing of Azathioprine 25 mg Tablets with complete manufacturing support for pharmaceutical companies, marketers, exporters, and franchise businesses. Our Third Party Manufacturing Services Include Private label manufacturing Contract manufacturing Custom brand manufacturing Loan license manufacturing DCGI-compliant production GMP-certified manufacturing Batch manufacturing documentation Product registration support Customized packaging and artwork Monopoly franchise packaging Bulk manufacturing capability Manufacturing Features Pharmaceutical-grade raw materials IP/BP/USP quality standards In-process quality control Finished product testing Stability-oriented formulation Moisture-controlled tablet manufacturing Blister and Alu-Alu packaging options ROOTOPTIN-25 from DIABGLYM combines effective immunosuppressive therapy, long-term autoimmune disease management, evidence-based clinical efficacy, and high-quality pharmaceutical manufacturing, making it an ideal product for physicians, rheumatologists, nephrologists, gastroenterologists, dermatologists, PCD Pharma Franchise partners, and Third Party Manufacturing clients seeking a reliable Azathioprine formulation.
Chandigarh
08048035312
+918699304069
Chat with us
Chat with us
